Mr. Garen Sarafian reports

BAUSCH HEALTH TO ANNOUNCE THIRD QUARTER 2026 RESULTS ON OCTOBER 28, 2026

Bausch Health Companies Inc. will release third quarter 2026 financial results after market close on Wednesday, Oct. 28, 2026. Bausch Health will host a live conference call and webcast at 5 p.m. U.S. ET to discuss results and provide a business update. All materials will be made available on the investor relations section of the Bausch Health website prior to the start of the call.

Conference call details

Date:  Wednesday, Oct. 28, 2026

Time:  5 p.m. U.S. ET

Webcast:  Bausch Health IR website

A replay of the conference call will be available on the investor relations website.

About Bausch Health Companies Inc.

Bausch Health Companies is a global diversified pharmaceutical company enriching lives through the company's relentless drive to deliver better health care outcomes. Bausch Health develops, manufactures and markets a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through the company's controlling interest in Bausch + Lomb. The company's ambition is to be a globally integrated health care company, trusted and valued by patients, HCPs, employees and investors.